Jordan U. Gutterman
Impact in
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 82
- Chronic Myeloid Leukemia Treatments 40
- Acute Myeloid Leukemia Research 28
- Oncology 132
- Cancer Immunotherapy and Biomarkers 30
- Neutropenia and Cancer Infections 25
- Co-authors
- Moshe Talpaz (61 shared papers)Razelle Kurzrock (55 shared papers)Jorge R. Quesada (30 shared papers)Evan M. Hersh (59 shared papers)José Manuel Trujillo (11 shared papers)Hagop Kantarjian (29 shared papers)Giora M. Mavligit (67 shared papers)E. M. Hersh (56 shared papers)
- Journals
- Cancer (32 papers)Journal of Clinical Oncology (9 papers)JNCI Journal of the National Cancer Institute (9 papers)Cancer Immunology Immunotherapy (9 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jordan U. Gutterman
316 papers receiving 16.1k citations
Jordan U. Gutterman's Hit Papers
Peers
Comparison fields: 5 of 152
- Hematology 4.3k
- Genetics 3.0k
- Immunology 4.8k
- Oncology 5.5k
- Pathology and Forensic Medicine 1.9k
Countries citing papers authored by Jordan U. Gutterman
This map shows the geographic impact of Jordan U. Gutterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan U. Gutterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan U. Gutterman more than expected).
Fields of papers citing papers by Jordan U. Gutterman
This network shows the impact of papers produced by Jordan U. Gutterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan U. Gutterman. The network helps show where Jordan U. Gutterman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jordan U. Gutterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 323 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Hit paper breakdown → | 1987 | 830 |
| 2 | The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis Hit paper breakdown → | 2007 | 751 |
| 3 | The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias Hit paper breakdown → | 1988 | 734 |
| 4 | Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia Hit paper breakdown → | 1984 | 704 |
| 5 | Cytokine therapeutics: lessons from interferonalpha. Hit paper breakdown → | 1994 | 618 |
| 6 | Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes Hit paper breakdown → | 1987 | 564 |
| 7 | Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia Hit paper breakdown → | 1986 | 556 |
| 8 | Clinical toxicity of interferons in cancer patients: a review. Hit paper breakdown → | 1986 | 530 |
| 9 | Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma Hit paper breakdown → | 1980 | 435 |
| 10 | Phase I study of recombinant tumor necrosis factor in cancer patients. | 1987 | 392 |
| 11 | 1992 | 345 | |
| 12 | 1991 | 339 | |
| 13 | 1982 | 329 | |
| 14 | Renal cell carcinoma: antitumor effects of leukocyte interferon. | 1983 | 266 |
| 15 | 1987 | 252 | |
| 16 | 1973 | 211 | |
| 17 | 1988 | 195 | |
| 18 | 2001 | 180 | |
| 19 | Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. | 1985 | 178 |
| 20 | 1985 | 171 |
About Jordan U. Gutterman
Jordan U. Gutterman is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 323 papers that have together received 17.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (48 papers), Chronic Myeloid Leukemia Treatments (40 papers), Chronic Lymphocytic Leukemia Research (37 papers), Immune Cell Function and Interaction (31 papers), Cancer Immunotherapy and Biomarkers (30 papers), Acute Myeloid Leukemia Research (28 papers), Neutropenia and Cancer Infections (25 papers) and Lymphoma Diagnosis and Treatment (23 papers). The work is most often cited by research in Hematology (4.3k citations), Genetics (3.0k citations), Immunology (4.8k citations), Oncology (5.5k citations) and Pathology and Forensic Medicine (1.9k citations). Jordan U. Gutterman has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Moshe Talpaz, Razelle Kurzrock, Jorge R. Quesada, Evan M. Hersh, José Manuel Trujillo, Hagop Kantarjian, Giora M. Mavligit, E. M. Hersh, Kenneth B. McCredie and Mark B. Blick. Their work appears in journals such as Cancer, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Cancer Immunology Immunotherapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.